Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
Stock Snapshot
As of today, Abbott(ABT) shares are valued at $100.18. The company's market cap stands at 175.55B, with a P/E ratio of 31.94 and a dividend yield of 2.47%.
During the trading session on 2026-07-23, Abbott(ABT) shares reached a daily high of $101.90 and a low of $100.07. At a current price of $100.18, the stock is +0.1% higher than the low and still -1.7% under the high.
Trading activity shows a volume of 9.96M, compared to an average daily volume of 14.65M.
Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $137.49 and a low of $81.97.
Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $137.49 and a low of $81.97.
ABT News
Social Security reform is back in the headlines, and the bipartisan PROMISE Act has put retirement income security under a brighter spotlight. With projections...
In its recently reported second-quarter 2026 results, Abbott Laboratories posted sales of US$12,593 million, up from US$11,142 million a year earlier, while net...
Abbott Laboratories stock has rebounded sharply in recent weeks after a tough start to the year, and both the Discounted Cash Flow (DCF) intrinsic value estimat...
Analyst ratings
79%
of 28 ratingsMore ABT News
Abbott Laboratories (ABT) just posted Q2 2026 revenue of about US$12.6b with basic EPS of US$0.53, alongside trailing twelve month revenue of roughly US$46.6b a...
Abbott Laboratories (NYSE:ABT) reported upbeat second-quarter results and raised its full-year adjusted earnings outlook on Thursday. Adjusted earnings came in...
BofA analyst Travis Steed raised the firm’s price target on Abbott (ABT) to $115 from $102 and keeps a Buy rating on the shares. Q2 results were “better than fe...
Abbott Laboratories (ABT) is back in focus after second quarter 2026 earnings topped market expectations, powered by Medical Devices and Diagnostics, and a high...
Key Points Demand for Abbott's medical devices and diagnostic tests is rising. The company has increased its dividend for 54 straight years. 10 stocks we lik...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.